TissueScan, Cancer Survey cDNA Array 96 - I
SKU
CSRT301
TissueScan Cancer Survey Panel 96 - I, containing five identical sets of 96 tissues covering eight (8) different cancers (Breast, Colon, Kidney, Liver, Lung, Ovarian, Prostate, Thyroid)
$1,590.00
In Stock*
Specifications
Reviews
Documents
| Product Manuals |
| FAQs |
| SDS |
Citations
HOTAIRM1 lncRNA is downregulated in clear cell renal cell carcinoma and inhibits the hypoxia pathway
Hamilton, Young, Jang et al
Cancer Lett. (2019) 472, 50-58 DOI: 10.1016/j.canlet.2019.12.022
Hamilton, Young, Jang et al
Cancer Lett. (2019) 472, 50-58 DOI: 10.1016/j.canlet.2019.12.022
Cited by 88
AI Summary: OriGene contributed 12 ccRCC tumor/normal matched pair RNA samples and multiple human tissue cDNA arrays (CSRT301, HKRT102) that were used to analyze HOTAIRM1 expression in the study.
Snippet: … The multiple human tissue cDNA arrays were obtained from Origene (CSRT301, HKRT102) and were normalized to ACTB;;- The 12 ccRCC tumor/normal matched pair RNA samples were obtained from Origene (see Supplemental Information). The multiple human tissue cDNA arrays were obtained from Origene (CSRT301, HKRT102) and were normalized to ACTB
Overexpression of the ATPase Inhibitory Factor 1 Favors a Non-metastatic Phenotype in Breast Cancer
García-Ledo, Nuevo-Tapioles, Cuevas-Martín et al
Front Oncol (2017) 7, 69 DOI: 10.3389/fonc.2017.00069
García-Ledo, Nuevo-Tapioles, Cuevas-Martín et al
Front Oncol (2017) 7, 69 DOI: 10.3389/fonc.2017.00069
AI Summary: OriGene's Cancer Survey Tissue Microarray was used in this study to analyze IF1 expression in normal and tumor breast tissue specimens, supporting the investigation of IF1’s role in breast cancer metastasis.
Snippet: The Cancer Survey Tissue Microarray (OriGene, Rockville, MD, USA) containing sections of formalin-fixed normal and tumor specimens of the breast were immunostained using the monoclonal anti-IF1 (1:200) antibody (22). Sections were counterstained with hematoxylin ... All 4 versions Cite SaveSaving
PLA2G7 associates with hormone receptor negativity in clinical breast cancer samples and regulates epithelial-mesenchymal transition in cultured breast cancer cells
Lehtinen, Vainio, Wikman et al
J Pathol Clin Res (2017) 3 (2), 123-138 DOI: 10.1002/cjp2.69
Lehtinen, Vainio, Wikman et al
J Pathol Clin Res (2017) 3 (2), 123-138 DOI: 10.1002/cjp2.69
AI Summary: OriGene’s TissueScan™ Cancer Survey cDNA Array 96 – I was used in this study to analyze PLA2G7 mRNA expression across multiple primary and metastatic tumor samples as well as non-malignant tissues, enabling the researchers to assess PLA2G7 expression patterns in various malignancies.
Snippet: TissueScan Cancer Survey cDNA Array 96 – I (Origene, Rockville, MD, USA) consisting of 96 samples from 65 primary and 7 metastatic tumour samples as well as 24 non‐malignant tissue samples derived from 8 different primary organs and provided with clinical information was utilised according to the manufacturer's instructions to analyse the expression pattern of PLA2G7 mRNA in multiple malignancies...
Showing 1-3 of 3 papers.
Powered by BizGenius
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen
complexities in the preparation of your product. International customers may expect an additional 1-2 weeks
in shipping.
Related Products
- Price:
- Actual Price:
Welcome to OriGene AI!
I'm your AI-powered guide to everything OriGene.
Ask me anything:
- Product specs
- Ordering help
- Technical questions
- How to find exactly what your experiment needs
Prefer a live agent? Connect with us by clicking the green chat icon, as seen in the image below or email our team at custsupport@origene.com.
